ViDES Trial (Vitamin D Extra Supplementation)

Description

The objective of the study is to compare supplementation with vitamin D at 800 IU/day to usual care for the first 28 days after birth with respect to 25 (OH) vitamin D levels and indicators of likely or plausible effects of vitamin D supplementation on the function or structure of the lung, bones, immune system, and brain in extremely premature (EP) infants who are \<28 weeks gestational age (GA) or \<1000 grams of birth weight (BW). The study results will be analyzed as intention to treat Bayesian analyses (Frequentist analyses will also be performed).

Conditions

Vitamin D Deficiency

Study Overview

Study Details

Study overview

The objective of the study is to compare supplementation with vitamin D at 800 IU/day to usual care for the first 28 days after birth with respect to 25 (OH) vitamin D levels and indicators of likely or plausible effects of vitamin D supplementation on the function or structure of the lung, bones, immune system, and brain in extremely premature (EP) infants who are \<28 weeks gestational age (GA) or \<1000 grams of birth weight (BW). The study results will be analyzed as intention to treat Bayesian analyses (Frequentist analyses will also be performed).

Randomized Trial of Enteral Vitamin D Supplementation in Infants < 28 Weeks Gestational Age or <1000 Grams Birth Weight

ViDES Trial (Vitamin D Extra Supplementation)

Condition
Vitamin D Deficiency
Intervention / Treatment

-

Contacts and Locations

Houston

The University of Texas Health Science Center at Houston, Houston, Texas, United States, 77006

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Infants born at \< 28 weeks gestational age (GA) or \<1000 grams birth weight (BW)
  • * Inborn
  • * Informed written consent in an Institutional Review Board (IRB)-approved manner
  • * GA \>32 weeks regardless of birth weight (BW)
  • * Any major congenital anomaly
  • * A known congenital nonbacterial infection
  • * Prenatal diagnosis of disorders that affect vitamin D absorption (e.g, cystic fibrosis)
  • * Such severe illness or immaturity that the attending neonatologist judges intensive care to be unjustified.

Ages Eligible for Study

24 Hours to 96 Hours

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

The University of Texas Health Science Center, Houston,

Maria del Mar Romero López, MD, PRINCIPAL_INVESTIGATOR, The University of Texas Health Science Center, Houston

Study Record Dates

2027-12-01